249 related articles for article (PubMed ID: 20223825)
1. Phosphorylation-induced conformational changes in the retinoblastoma protein inhibit E2F transactivation domain binding.
Burke JR; Deshong AJ; Pelton JG; Rubin SM
J Biol Chem; 2010 May; 285(21):16286-93. PubMed ID: 20223825
[TBL] [Abstract][Full Text] [Related]
2. Structure of the Rb C-terminal domain bound to E2F1-DP1: a mechanism for phosphorylation-induced E2F release.
Rubin SM; Gall AL; Zheng N; Pavletich NP
Cell; 2005 Dec; 123(6):1093-106. PubMed ID: 16360038
[TBL] [Abstract][Full Text] [Related]
3. Separation of anti-proliferation and anti-apoptotic functions of retinoblastoma protein through targeted mutations of its A/B domain.
Chau BN; Pan CW; Wang JY
PLoS One; 2006 Dec; 1(1):e82. PubMed ID: 17183714
[TBL] [Abstract][Full Text] [Related]
4. Multiple mechanisms for E2F binding inhibition by phosphorylation of the retinoblastoma protein C-terminal domain.
Burke JR; Liban TJ; Restrepo T; Lee HW; Rubin SM
J Mol Biol; 2014 Jan; 426(1):245-55. PubMed ID: 24103329
[TBL] [Abstract][Full Text] [Related]
5. Conservation and divergence of C-terminal domain structure in the retinoblastoma protein family.
Liban TJ; Medina EM; Tripathi S; Sengupta S; Henry RW; Buchler NE; Rubin SM
Proc Natl Acad Sci U S A; 2017 May; 114(19):4942-4947. PubMed ID: 28439018
[TBL] [Abstract][Full Text] [Related]
6. Structures of inactive retinoblastoma protein reveal multiple mechanisms for cell cycle control.
Burke JR; Hura GL; Rubin SM
Genes Dev; 2012 Jun; 26(11):1156-66. PubMed ID: 22569856
[TBL] [Abstract][Full Text] [Related]
7. A potent transrepression domain in the retinoblastoma protein induces a cell cycle arrest when bound to E2F sites.
Sellers WR; Rodgers JW; Kaelin WG
Proc Natl Acad Sci U S A; 1995 Dec; 92(25):11544-8. PubMed ID: 8524800
[TBL] [Abstract][Full Text] [Related]
8. The extreme COOH terminus of the retinoblastoma tumor suppressor protein pRb is required for phosphorylation on Thr-373 and activation of E2F.
Gorges LL; Lents NH; Baldassare JJ
Am J Physiol Cell Physiol; 2008 Nov; 295(5):C1151-60. PubMed ID: 18768921
[TBL] [Abstract][Full Text] [Related]
9. A Strategy for Direct Chemical Activation of the Retinoblastoma Protein.
Pye CR; Bray WM; Brown ER; Burke JR; Lokey RS; Rubin SM
ACS Chem Biol; 2016 May; 11(5):1192-7. PubMed ID: 26845289
[TBL] [Abstract][Full Text] [Related]
10. The central acidic domain of MDM2 is critical in inhibition of retinoblastoma-mediated suppression of E2F and cell growth.
Sdek P; Ying H; Zheng H; Margulis A; Tang X; Tian K; Xiao ZX
J Biol Chem; 2004 Dec; 279(51):53317-22. PubMed ID: 15485814
[TBL] [Abstract][Full Text] [Related]
11. Structural basis for the recognition of the E2F transactivation domain by the retinoblastoma tumor suppressor.
Lee C; Chang JH; Lee HS; Cho Y
Genes Dev; 2002 Dec; 16(24):3199-212. PubMed ID: 12502741
[TBL] [Abstract][Full Text] [Related]
12. Regulation of the Chlamydomonas cell cycle by a stable, chromatin-associated retinoblastoma tumor suppressor complex.
Olson BJ; Oberholzer M; Li Y; Zones JM; Kohli HS; Bisova K; Fang SC; Meisenhelder J; Hunter T; Umen JG
Plant Cell; 2010 Oct; 22(10):3331-47. PubMed ID: 20978220
[TBL] [Abstract][Full Text] [Related]
13. Structural Conservation and E2F Binding Specificity within the Retinoblastoma Pocket Protein Family.
Liban TJ; Thwaites MJ; Dick FA; Rubin SM
J Mol Biol; 2016 Oct; 428(20):3960-3971. PubMed ID: 27567532
[TBL] [Abstract][Full Text] [Related]
14. The N-Terminal Phosphorylation of RB by p38 Bypasses Its Inactivation by CDKs and Prevents Proliferation in Cancer Cells.
Gubern A; Joaquin M; Marquès M; Maseres P; Garcia-Garcia J; Amat R; González-Nuñez D; Oliva B; Real FX; de Nadal E; Posas F
Mol Cell; 2016 Oct; 64(1):25-36. PubMed ID: 27642049
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of retinoblastoma protein (Rb) phosphorylation at serine sites and an increase in Rb-E2F complex formation by silibinin in androgen-dependent human prostate carcinoma LNCaP cells: role in prostate cancer prevention.
Tyagi A; Agarwal C; Agarwal R
Mol Cancer Ther; 2002 May; 1(7):525-32. PubMed ID: 12479270
[TBL] [Abstract][Full Text] [Related]
16. Disruption of retinoblastoma protein function by coexpression of its C pocket fragment.
Welch PJ; Wang JY
Genes Dev; 1995 Jan; 9(1):31-46. PubMed ID: 7828850
[TBL] [Abstract][Full Text] [Related]
17. The E2F family of transcription factors from Arabidopsis thaliana. Novel and conserved components of the retinoblastoma/E2F pathway in plants.
Mariconti L; Pellegrini B; Cantoni R; Stevens R; Bergounioux C; Cella R; Albani D
J Biol Chem; 2002 Mar; 277(12):9911-9. PubMed ID: 11786543
[TBL] [Abstract][Full Text] [Related]
18. Molecular Determinants for the Inactivation of the Retinoblastoma Tumor Suppressor by the Viral Cyclin-dependent Kinase UL97.
Iwahori S; Hakki M; Chou S; Kalejta RF
J Biol Chem; 2015 Aug; 290(32):19666-80. PubMed ID: 26100623
[TBL] [Abstract][Full Text] [Related]
19. MAZ induces MYB expression during the exit from quiescence via the E2F site in the MYB promoter.
Álvaro-Blanco J; Urso K; Chiodo Y; Martín-Cortázar C; Kourani O; Arco PG; Rodríguez-Martínez M; Calonge E; Alcamí J; Redondo JM; Iglesias T; Campanero MR
Nucleic Acids Res; 2017 Sep; 45(17):9960-9975. PubMed ID: 28973440
[TBL] [Abstract][Full Text] [Related]
20. Retinoblastoma-repression of E2F-dependent transcription depends on the ability of the retinoblastoma protein to interact with E2F and is abrogated by the adenovirus E1A oncoprotein.
Arroyo M; Raychaudhuri P
Nucleic Acids Res; 1992 Nov; 20(22):5947-54. PubMed ID: 1461728
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
